Related Experiment Video
Updated: May 21, 2026
09:38
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
1John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA. mortond@JCWI.org
Clinical & Experimental Metastasis
|June 26, 2012
Abstract:
This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.
